STAT6 and colitis: Building on our in vitro findings that STAT6 inhibition enhances the stability and suppressive function of iTregs, we next investigated whether in vivo administration of the STAT6 inhibitor AS1517499 could similarly enhance Treg activity and attenuate inflammation in a model of acute colitis.